WebThe versatility of the GeneTAC™ platform allows us to design GeneTAC™ molecules toward a specific nucleotide repeat expansion target, regardless of repeat number, and tailor it to address the underlying disease-specific dysfunction in gene regulation through restoration of transcription or reduction of toxic gene product levels. WebDec 20, 2024 · In addition to my work at Aegis, I consult with companies on the design and development of digital therapeutics and games for impact or education, focusing on translating customer/user insights ...

Nested Therapeutics LinkedIn

WebDesign Therapeutics 1,414 followers on LinkedIn. We are a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC™ gene targeted chimera small molecules. The company’s GeneTAC™ molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address … WebDeepa brings over 20+ years of healthcare experience spanning operations, venture capital, and investment banking. She most recently served as … 63號碼頭貨櫃動態

Our Approach – Design Therapeutics

WebSep 8, 2024 · Design Therapeutics, Inc. (Nasdaq: DSGN) is a biotechnology company developing a new class of therapies based on a platform of gene targeted chimera (GeneTAC™) small molecules. The company’s ... WebNested Therapeutics 3,468 followers on LinkedIn. Nested aims to advance precision oncology medicine by finding new driver mutations hiding in plain sight. We are Nested Therapeutics, a biotech company inspired by service and driven by a desire to make a meaningful impact. We are creative innovators who challenge our own assumptions as … WebDesign Therapeutics LinkedIn Design Therapeutics Biotechnology Research Carlsbad, CA 1,401 followers Follow View all 67 employees About us We are a clinical-stage biotechnology company... 63車體乙式代車費日額型